Cintas Corporation CTAS
199.91
2.23
1.13%
as of 25 Sep
- Market cap
- $79.0B
- P/E
- 39.0×
Follow CTAS
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Cintas Corporation (CTAS) EBITDA
Cintas Corporation's EBITDA for fiscal 2026 was $3.1B, up 9.30% from $2.9B in fiscal 2025. Over the past ten years it has ranged from $838.7M (fiscal 2015) to $3.1B (fiscal 2026) — the current reading is the highest in ten years. EBITDA has risen for 11 consecutive fiscal years. Cintas Corporation ranks 2nd of 35 Specialty Business Services companies by EBITDA.
EBITDA, annual
Annual
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $3.1B | 9.30% |
| FY2025 | $2.9B | 13.00% |
| FY2024 | $2.5B | 13.66% |
| FY2023 | $2.2B | 11.82% |
| FY2022 | $2.0B | 12.05% |
| FY2021 | $1.8B | 15.03% |
| FY2020 | $1.5B | 3.22% |
| FY2019 | $1.5B | 21.51% |
| FY2018 | $1.2B | 26.69% |
| FY2017 | $970.3M | 3.86% |
Quarterly
| Period | EBITDA | Change |
|---|---|---|
| May 2026 | $803.8M | 1.93% |
| Feb 2026 | $788.6M | 0.68% |
| Nov 2025 | $783.2M | 5.30% |
| Aug 2025 | $743.8M | 2.75% |
| 42 more quarters | Free account |
Against its own ten years
Low $838.7M
High $3.1B
Ten-year median
$1.7B
Current reading's percentile
100
EBITDA against peers
| Company | EBITDA |
|---|---|
| RELX RELX PLC compare | $7.7B |
| CTAS Cintas Corporation | $3.1B |
| RTO Rentokil Initial PLC compare | $2.0B |
| CPRT Copart, Inc. compare | $1.9B |
| ARMK Aramark compare | $1.4B |
| AMTM Amentum Holdings, Inc. compare | $1.0B |
| ULS UL Solutions Inc. compare | $752.0M |
| DLB Dolby Laboratories compare | $342.4M |
| UNF Unifirst Corporation compare | $286.1M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CTAS
- Revenue
- Net income
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement